Experimental influenza vaccine
Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins
https://clinicaltrials.gov/ct2/show/NCT05755620
Clinical trial, experimental universal influenza vaccine
National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC),
(part of National Institutes of Health)
Enrolling volunteers, Duke University, Durham, North Carolina
Phase 1 trial
H1ssF-3928 mRNA-LNP, for safety and ability to induce an immune response.
N = up to 50 healthy volunteers, (18 through 49)
Three groups of 10 participants each
10, 25 and 50 micrograms
After evaluation of the data to determine an optimum dosage,
an additional 10 to receive the optimum dosage
Study include a group, receive a current quadrivalent.
Comparison between “immunogenicity and safety”
Follow-up appointments for up to one year
Annual seasonal flu vaccines
Valuable tools in controlling the spread and severity of influenza
Do not provide immunity against every flu strain.
Each year is based on prediction
Vaccine manufacturers then need time
(dominant strains of the virus can change)
An effective universal flu vaccine
Acting NIAID Director Hugh Auchincloss
Protecting its recipients against a wide variety of strains,
ideally providing durable long-term immunity.
“A universal influenza vaccine would be a major public health achievement and could eliminate the need for both annual development of seasonal influenza vaccines, as well as the need for patients to get a flu shot each year”
Defence against the spread of a future flu pandemic.
Both vaccines use a specific portion of a flu protein,
Hemagglutinin (HA) stern (not head) flu protein
UK cements 10-year-partnership with Moderna in major boost for vaccines and research
to produce up to 250 million vaccines per year
£1bn deal with the UK government
UK government has committed to buying Moderna’s vaccines for the next decade.
Harwell, Oxfordshire
https://www.bbc.co.uk/news/uk-england-oxfordshire-64856379
Innovation and Technology Centre built by the 2025
Moderna
provide the UK public with access to mRNA vaccines for a wide range of respiratory diseases
Questions
Control of antigen dose?
How long antigen will be produced for?
Degree of systemic distribution?
Degree of systemic inflammation?
-
15:35
Dr. John Campbell
22 days agoMidazolam deaths in the UK
34.6K166 -
1:04:53
ReasonTV
14 hours agoPhil Magness: Who Really Pays The Most Taxes?
3272 -
LIVE
Rekieta Law
2 hours agoDaniel Perry Pardoned, Cohen Pressed, NFL Shaken, Clarence Thomas Grilled, ADL Most Affected
2,907 watching -
LIVE
Price of Reason
6 hours agoAmazon Wants FEMINIST Tomb Raider! Gaming DEI Agenda EXPOSED w/ Dreadroberts
1,831 watching -
1:38:48
TheMonicaCrowleyPodcast
10 hours agoThe 2020 to 2024 Trek Clean Elections
3.95K5 -
LIVE
Akademiks
3 hours agoHappy Birthday Big AK. Lets bring it in together chat.
6,565 watching -
1:28:57
The Charlie Kirk Show
5 hours agoTHOUGHTCRIME Ep. 44 — Is Doxxing Dead? Poo-Loving Libs? The Truth About Pearl Harbor?
46.9K53 -
1:18:32
Kim Iversen
7 hours agoBig Pharma Hopes For Another Cash Cow Vaccine With Bird Flu GAIN OF FUNCTION Research
37.3K134 -
3:14:17
Melonie Mac
8 hours agoGo Boom Live Ep 4!
29.4K16 -
1:11:58
Precision Rifle Network
1 day agoGuns & Grub S2E4
26.3K4